本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

武田制药

15.38
+0.06000.39%
盘前14.01-1.3700-8.91%04:25 EDT
成交量:122.88万
成交额:1,888.79万
市值:485.44亿
市盈率:37.15
高:15.43
开:15.40
低:15.34
收:15.32
数据加载中...
2020/01/27

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/01/24

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/24

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/22

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/22

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

SEC问询函

[Cover]Correspondence
2019/11/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/06

超过5%披露

General statement of acquisition of beneficial ownership
2019/11/06

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/10/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]